Your browser doesn't support javascript.
loading
Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia/lymphoma.
Sharma, Kamal; Janik, John E; O'Mahony, Deirdre; Stewart, Donn; Pittaluga, Stefania; Stetler-Stevenson, Maryalice; Jaffe, Elaine S; Raffeld, Mark; Fleisher, Thomas A; Lee, Cathryn C; Steinberg, Seth M; Waldmann, Thomas A; Morris, John C.
Afiliação
  • Sharma K; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Janik JE; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • O'Mahony D; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Stewart D; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Pittaluga S; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Stetler-Stevenson M; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Jaffe ES; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Raffeld M; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Fleisher TA; Clinical Pathology Department, Mark O. Hatfield Clinical Research Center, NIH, Bethesda, Maryland.
  • Lee CC; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Steinberg SM; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Waldmann TA; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. tawald@helix.nih.gov.
  • Morris JC; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Clin Cancer Res ; 23(1): 35-42, 2017 Jan 01.
Article em En | MEDLINE | ID: mdl-27486175
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Assunto principal: Vírus Linfotrópico T Tipo 1 Humano / Infecções por HTLV-I / Leucemia-Linfoma de Células T do Adulto / Alemtuzumab / Antineoplásicos Imunológicos Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Assunto principal: Vírus Linfotrópico T Tipo 1 Humano / Infecções por HTLV-I / Leucemia-Linfoma de Células T do Adulto / Alemtuzumab / Antineoplásicos Imunológicos Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article